buflomedil has been researched along with Diabetes Mellitus, Adult-Onset in 6 studies
buflomedil: RN given refers to parent cpd; synonym LL 1656 refers to HCl; structure
Excerpt | Relevance | Reference |
---|---|---|
" Buflomedil, a vasoactive substance with hemorheological properties, has been widely used in the treatment of intermittent claudication." | 9.09 | Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication. ( Diamantopoulos, EJ; Grigoriadou, M; Ifanti, G; Raptis, SA, 2001) |
"A total of 26 non-insulin-dependent diabetic patients were enrolled for a clinical study of the effect of buflomedil on microalbuminuria." | 9.07 | The effect of oral buflomedil on microalbuminuria in non-insulin-dependent diabetic patients. ( Chuang, LM; Lin, BJ; Tai, TY; Tseng, CH; Wu, HP, 1992) |
" Buflomedil, a vasoactive substance with hemorheological properties, has been widely used in the treatment of intermittent claudication." | 5.09 | Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication. ( Diamantopoulos, EJ; Grigoriadou, M; Ifanti, G; Raptis, SA, 2001) |
"A total of 26 non-insulin-dependent diabetic patients were enrolled for a clinical study of the effect of buflomedil on microalbuminuria." | 5.07 | The effect of oral buflomedil on microalbuminuria in non-insulin-dependent diabetic patients. ( Chuang, LM; Lin, BJ; Tai, TY; Tseng, CH; Wu, HP, 1992) |
"Eighty patients with Type 2 diabetes were studied." | 2.70 | Effects of buflomedil on early carotid atherosclerosis in Type 2 diabetic patients. ( Charalabides, J; Gerolimou, B; Karmaniolas, K; Leontiades, E; Mantzara, F; Migdalis, IN; Varvarigos, N, 2001) |
"Patients with type 2 diabetes mellitus have an increased vascular risk and a series of modifiable risk factors play a crucial role in the atherosclerotic process." | 2.45 | Buflomedil: potential new indications for an old agent. ( Hatzitolios, AI; Papadimitriou, DK; Tsantilas, D; Tziomalos, K, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tsantilas, D | 2 |
Hatzitolios, AI | 2 |
Tziomalos, K | 2 |
Papadimitriou, DK | 1 |
Karamitsos, D | 1 |
Papadimitriou, D | 1 |
Migdalis, IN | 1 |
Varvarigos, N | 1 |
Charalabides, J | 1 |
Leontiades, E | 1 |
Gerolimou, B | 1 |
Mantzara, F | 1 |
Karmaniolas, K | 1 |
Brunner, M | 1 |
Göring, HD | 1 |
Diamantopoulos, EJ | 1 |
Grigoriadou, M | 1 |
Ifanti, G | 1 |
Raptis, SA | 1 |
Tseng, CH | 1 |
Tai, TY | 1 |
Wu, HP | 1 |
Chuang, LM | 1 |
Lin, BJ | 1 |
1 review available for buflomedil and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Buflomedil: potential new indications for an old agent.
Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Peripheral Vascular Diseases; Pyrrolidines | 2009 |
4 trials available for buflomedil and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Effects of buflomedil on skin blood flow in patients with type 2 diabetes mellitus without overt micro- or macroangiopathy.
Topics: Biomarkers; Blood Flow Velocity; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Foot Ul | 2011 |
Effects of buflomedil on early carotid atherosclerosis in Type 2 diabetic patients.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; Carotid Artery Diseases; Carotid Artery, Commo | 2001 |
Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Erythrocyte Deformability; Female; Hemorheology; Hum | 2001 |
The effect of oral buflomedil on microalbuminuria in non-insulin-dependent diabetic patients.
Topics: Adult; Aged; Albuminuria; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; | 1992 |
1 other study available for buflomedil and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
[Retrograde venous perfusion (RVP in ulcero-mutilating neuropathy].
Topics: Alcoholism; Anti-Inflammatory Agents; Anticoagulants; Dexamethasone; Diabetes Complications; Diabete | 2001 |